| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| ChannelAdvisor (ECOM) | Goldman, Sachs/ Stifel | $86.25 | n.a. | |||
| First NBC Bank Holding (tba) | SANDLER O’NEILL + PARTNERS/ Keefe, Bruyette & Woods (A Stifel Company ) | $115.00 | n.a. | |||
| HD Supply Holdings (tba) | BofA Merrill Lynch/ Barclays/ J.P. Morgan/ Credit Suisse | $1,000.00 | n.a. | |||
| Kamada Ltd. (KMDA) | Morgan Stanley/ Jefferies | $69.00 | n/c | |||
| Liquid Holdings Group (LIQD) | Sandler ONeill & Partners | $49.16 | n.a. | |||
| Portola Pharmaceuticals (PTLA) | Morgan Stanley/ Credit Suisse | $115.00 | n.a. | |||
| William Lyon Homes (WLH) | Credit Suisse/ Citigroup/ J.P. Morgan | $200.00 | n.a. | |||
| n.a. (not available) | ||||||
| n/c (no call) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| ADMA Biologics (tba) | Oppenheimer/ BMO Capital Markets | 2.10 | $13.50 | $15.50 | $30.45 | 1-Star |
| BioAmber (BIOA) | Credit Suisse | 8.00 | $15.00 | $17.00 | $128.00 | 1-Star |
| Blackhawk Network Holdings (HAWK) | Goldman, Sachs/ BofA Merrill Lynch/ Citigroup/ Deutsche Bank Securities | 10.00 | $20.00 | $22.00 | $210.00 | 2-Stars |
| SeaWorld Entertainment (SEAS) | Goldman, Sachs/ J.P. Morgan | $500.00 | 2-Stars | |||
| SeaWorld Entertainment (SEAS) | Goldman, Sachs/ J.P. Morgan | 20.00 | $24.00 | $27.00 | $510.00 | 2-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 8, 2013 | Manager(s) | Offered | Raised | Price | 4/12/13 | Change |
| Chimerix (CMRX) | Morgan Stanley/ Cowen and Company | 7.32 | $102.48 | $14.00 | $18.17 | 29.79% |
| Rally Software Development (RALY) | Deutsche Bank Securities/ Piper Jaffray | 6.00 | $84.00 | $14.00 | $17.81 | 27.21% |
| Taylor Morrison Home (TMHC) | Credit Suisse/ Citigroup/ Zelman Partners | 28.57 | $628.58 | $22.00 | $24.30 | 10.45% |
| KNOT Offshore Partners LP (KNOP) | BofA Merrill Lynch/ Citigroup | 7.45 | $156.45 | $21.00 | $22.23 | 5.86% |
| EVERTEC (EVTC) | Goldman, Sachs/ J.P. Morgan | 25.26 | $505.26 | $20.00 | $20.44 | 2.20% |
| Omthera Pharmaceuticals (OMTH) | BofA Merrill Lynch/ Barclays/ Leerink Swann | 8.00 | $64.00 | $8.00 | $7.50 | -6.25% |
